BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 12687617)

  • 1. Peroxisome proliferator-activated receptor alpha-dependent induction of cell surface antigen Ly-6D gene in the mouse liver.
    Dadras SS; Cook WS; Yeldandi AV; Cao WQ; Rao MS; Wang Z; Reddy JK
    Gene Expr; 2001; 9(4-5):173-81. PubMed ID: 11444527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor alpha target genes.
    Mandard S; Müller M; Kersten S
    Cell Mol Life Sci; 2004 Feb; 61(4):393-416. PubMed ID: 14999402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.
    Cunningham ML; Collins BJ; Hejtmancik MR; Herbert RA; Travlos GS; Vallant MK; Stout MD
    PPAR Res; 2010; 2010():. PubMed ID: 20953357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing environmental enrichment for Sprague Dawley rats: Exemplary insights into the liver proteome.
    Roschke NN; Hillebrandt KH; Polenz D; Klein O; Gassner JMGV; Pratschke J; Krenzien F; Sauer IM; Raschzok N; Moosburner S
    PLoS One; 2024; 19(4):e0297497. PubMed ID: 38635534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription of the Human Microsomal Epoxide Hydrolase Gene (EPHX1) Is Regulated by PARP-1 and Histone H1.2. Association with Sodium-Dependent Bile Acid Transport.
    Peng H; Zhu QS; Zhong S; Levy D
    PLoS One; 2015; 10(5):e0125318. PubMed ID: 25992604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic dipeptide cyclo (His-Pro) significantly altered plasma proteome in streptozocin-induced diabetic rats and genetically-diabetic (ob/ob) mice.
    Choi SA; Yun JW; Park HS; Choi JW
    Mol Biol Rep; 2013 Feb; 40(2):1753-65. PubMed ID: 23086277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
    Woods CG; Kosyk O; Bradford BU; Ross PK; Burns AM; Cunningham ML; Qu P; Ibrahim JG; Rusyn I
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):267-77. PubMed ID: 17950772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
    Qi C; Zhu Y; Reddy JK
    Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases.
    Latruffe N; Cherkaoui Malki M; Nicolas-Frances V; Clemencet MC; Jannin B; Berlot JP
    Biochem Pharmacol; 2000 Oct; 60(8):1027-32. PubMed ID: 11007938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligands.
    White IR; Man WJ; Bryant D; Bugelski P; Camilleri P; Cutler P; Hayes W; Holbrook JD; Kramer K; Lord PG; Wood J
    Proteomics; 2003 Apr; 3(4):505-12. PubMed ID: 12687617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice.
    DeLuca JG; Doebber TW; Kelly LJ; Kemp RK; Molon-Noblot S; Sahoo SP; Ventre J; Wu MS; Peters JM; Gonzalez FJ; Moller DE
    Mol Pharmacol; 2000 Sep; 58(3):470-6. PubMed ID: 10953038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.
    Yang XY; Wang LH; Chen T; Hodge DR; Resau JH; DaSilva L; Farrar WL
    J Biol Chem; 2000 Feb; 275(7):4541-4. PubMed ID: 10671476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice.
    Edvardsson U; Bergström M; Alexandersson M; Bamberg K; Ljung B; Dahllöf B
    J Lipid Res; 1999 Jul; 40(7):1177-84. PubMed ID: 10393202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.
    Cheng S; Afif H; Martel-Pelletier J; Pelletier JP; Li X; Farrajota K; Lavigne M; Fahmi H
    J Biol Chem; 2004 May; 279(21):22057-65. PubMed ID: 15023995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643.
    Edvardsson U; Alexandersson M; Brockenhuus von Löwenhielm H; Nyström AC; Ljung B; Nilsson F; Dahllöf B
    Electrophoresis; 1999; 20(4-5):935-42. PubMed ID: 10344269
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.